COVID-19 vaccine round-up: Johnson & Johnson begins Phase 3 trials in the United States
COVID-19 vaccine round-up: Johnson & Johnson begins Phase 3 trials in the United States

A large scale trial has kicked off today.

Johnson & Johnson's coronavirus vaccine began its Phase 3 clinical trials.

This is the fourth COVID-19 vaccine candidate to enter the final stage here in the US.